4-(4-Bromophenyl)-2,6-diphenylpyrimidine

Introduction

CAS No. :	58536-46-2	MDL No. :	MFCD00474667
Formula :	C22H15BrN2	Boiling Point :	No data available
Linear Structure Formula :	-	InChI Key :	GHDBFGUOBVYEOV-UHFFFAOYSA-N
M.W :	387.27	Pubchem ID :	1714899
Synonyms :

Physicochemical Properties

Num. heavy atoms :	25
Num. arom. heavy atoms :	24
Fraction Csp3 :	0.0
Num. rotatable bonds :	3
Num. H-bond acceptors :	2.0
Num. H-bond donors :	0.0
Molar Refractivity :	106.04
TPSA :	25.78 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	No
P-gp substrate :	Yes
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	Yes
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	Yes
Log Kp (skin permeation) :	-4.49 cm/s

Lipophilicity

Log Po/w (iLOGP) :	3.92
Log Po/w (XLOGP3) :	5.88
Log Po/w (WLOGP) :	6.24
Log Po/w (MLOGP) :	4.72
Log Po/w (SILICOS-IT) :	6.19
Consensus Log Po/w :	5.39

Druglikeness

Lipinski :	1.0
Ghose :	None
Veber :	0.0
Egan :	1.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-6.46
Solubility :	0.000135 mg/ml ; 0.000000348 mol/l
Class :	Poorly soluble
Log S (Ali) :	-6.19
Solubility :	0.000248 mg/ml ; 0.000000639 mol/l
Class :	Poorly soluble
Log S (SILICOS-IT) :	-9.99
Solubility :	0.0000000398 mg/ml ; 0.0000000001 mol/l
Class :	Poorly soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	2.0
Synthetic accessibility :	2.57

Signal Word:	Warning	Class:
Precautionary Statements:	P305+P351+P338	UN#:
Hazard Statements:	H315-H319	Packing Group:
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine